CHD from the Perspective of 2023
June 29, 2023
Speaker:
Yana Arturovna Orlova, MD, PhD, Head of the Department of Therapy, Faculty of Fundamental Medicine, Lomonosov Moscow State University; Head of the Department of Age-Associated Diseases, Medical Research and Education Center, Lomonosov Moscow State University; Honored Doctor of the Russian Federation
The lecture will cover the most current data on optimal drug therapy for patients with stable coronary artery disease, improving the prognosis for these patients, and prescribing lipid-lowering and antithrombotic therapy in accordance with the 2023 clinical guidelines.
Program:
13:00 - 13:20 - Lecture "Coronary Heart Disease Treatment from a 2023 Perspective"
13:20 – 13:40 - Lecture "Facets of Residual Cardiovascular Risk" (sponsored by Abbott Laboratories, no CME points awarded)
13:40 – 14:00 - Question and Answer Session
0:00 Start Screen
1:17 Lecture Part 1. Introduction
1:37 Prevalence of Coronary Heart Disease. Main Goals of Coronary Heart Disease Treatment
7:04 Possible Drug Combinations: The "Diamond Approach"
21:31 PCI vs. OMT: The ISCHEMIA Study Algorithm for managing patients with stable coronary artery disease
31:11 Q&A
37:36 Lecture Part 2. "Facets of Residual Cardiovascular Risk"
16:13:26 Q&A